MICHAEL P. BAILEY - 15 Feb 2022 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC.

Role
President & CEO, Director
Signature
/s/ Danielle V. Holland, attorney-in-fact
Issuer symbol
N/A
Transactions as of
15 Feb 2022
Net transactions value
$0
Form type
4
Filing time
17 Feb 2022, 15:58:40 UTC
Previous filing
03 Sep 2021
Next filing
22 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVEO Stock Option (right to buy) Award $0 +789,717 $0.000000 789,717 15 Feb 2022 Common Stock 789,717 $3.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in equal monthly installments from February 15, 2022 through February 15, 2026, subject to the Reporting Person's continued service to the Company.